Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

NovoCure Ltd

NASDAQ: NVCR · Industrial Applications and Services · 6 alerts · CIK 1645113

Share price
$11.30Close, Nov 16
Market cap
$1.32B
Shares outstanding
116.92MLatest SEC cover page
Sector
Industrial Applications and Services
Industry
Surgical & Medical Instruments & ApparatusSIC 3841

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All NovoCure Ltd filings on SEC EDGAR ↗

9:01 AM ET 8-K
Regulatory Approval

NovoCure Regulatory Approval

NovoCure received approval from Japan's Ministry of Health, Labour and Welfare for its Optune Pax device to treat adult patients with unresectable locally advanced pancreatic cancer. The approval was based on Phase 3 PANOVA-3 trial results showing statistically significant improvement in median overall survival. This marks a major commercial milestone for the company in Japan, where pancreatic cancer is the fourth leading cause of cancer death.

Counterparty
Ministry of Health, Labour and Welfare (MHLW)

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.